Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescent Nanoparticles Conjugated Long-acting Somatostatin Analog for Potent Suppression and Bioimaging Breast Cancer

NCT04138342 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT04138342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescent Nanoparticles Conjugated Long-acting Somatostatin Analog for Potent Suppression and Bioimaging Breast Cancer
Lead sponsor
Al-Azhar University
Phase
Phase 1
Overall status
Unknown status
Start date
September 15, 2019
Completion date
December 13, 2022
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, skin cancer, skin diseases